Immunosuppressed patients outside of the US should have access to the monoclonal antibody Bebtelovimab, the only therapeutic antibody efficient...
10/08/2022
In this month's newsletter have a look at future events and opportunities within FEAM...
28/07/2022
26
Oct2022
19
Oct2022
07
Jul2022
23
Jun2022
22
Jun2022
19
May2022